While myr-AKT and YAP5SA robustly induced liver tumors after 6 weeks, we found a significant reduction in hepatocellular carcinoma formation due to the presence of MY-COMP in this model (Fig. 4B–D). The gene discussed is AKT1; the disease is hepatocellular carcinoma.